PRESS
POSTED 19 May 2020
October 2011
Veryan closes £5.0m funding round to develop novel BioMimics 3D stent technology and complete the MIMICS pivotal study.
©Veryan Medical 2022
BioMimics 3D Vascular Stent System has FDA and CE Mark approval.
BioMimics 3D & Swirling Flow Stent are registered trademarks of Veryan Medical Limited.
Veryan Medical Limited is a member of the Otsuka Medical Devices group of companies.
CAUTION: Federal law restricts this device to sale by or on the order of a physician.
PAM 14 Version 3.0
